Dr. Habtezion is a tenured Associate Professor of Medicine (Gastroenterology & Hepatology) and faculty in the Immunology PhD program and Institute for Immunity, Transplantation and Infection at Stanford University. Dr. Habtezion is the endowed Ballinger-Swindells Family Scholar, Associate Dean for Academic Affairs in the School of Medicine and a member of Stanford Pancreas Cancer Research Group, Stanford Diabetes Research Center, Stanford Neuroscience Institute, Stanford Bio-X, and a fellow of Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H), and Stanford maternal & Child Health Research Institute.

Dr. Habtezion developed the first Stanford Inflammatory Bowel Disease (IBD) registry with biobank and leads a translational lab. Her laboratory supported by multiple NIH, Department of Defense, and Foundation grants investigates inflammatory mechanisms in diseases affecting the pancreas and intestine with goals of identifying targetable pathways to ameliorate disease. In 2011-2012 she was the named Digestive Disease Investigator, in 2012-2015 she received the Robert Wood Johnson Harold Amos Medical Faculty Development Award, in 2013 she received the Division of Gastroenterology & Hepatology Teaching Award, in 2016 the Immunology Faculty Mentor of the Year, in 2017 she received Synergy Award from the Kenneth Rainin Foundation for her research in IBD. For several years, she served as a regular NIH study section member and National Scientific Advisory Committee (NASC) member for the Crohn’s & Colitis Foundation. In 2017 she was elected into the American Society for Clinical Investigation, and into the American Pancreatic Association (APA) Council. Recently she was named the President-elect for the American Pancreas Association.